>Pfizer is the world's largest research-based biomedical and pharmaceutical company. Located in New York, with major research and development locations in the United States and England. (www.pfizer.com)
>Encysive Pharmaceuticals is a biopharmaceutical company engaged in the discovery, development and commercialization of novel, synthetic, small molecule compounds to address unmet medical needs. (www.Encysive.com)
Pfizer will make a cash tender offer for all issued and outstanding shares of Encysive for $2.35 per share, representing an equity value of approximately $195 million.
